Neuropathic pain (NP) is a multifactorial pathological state with no cure. Increased LPA synthesis after nerve injury can trigger demyelination, causing NP. LPA/LPAR signalling contributes to maintenance of NP. New therapeutics targeting LPA production and signalling may be effective in alleviating NP.